G, R., A, C., D, F., C, N., V, V. d. E., PK, G., & BS, B. (2026). Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data. CNS drugs, 40(3), 359. https://doi.org/10.1007/s40263-025-01256-7
Chicago Style (17th ed.) CitationG, Rached, Campana A, Fiani D, Nguyen C, Van den Eynde V, Gillman PK, and Barnett BS. "Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data." CNS Drugs 40, no. 3 (2026): 359. https://doi.org/10.1007/s40263-025-01256-7.
MLA (9th ed.) CitationG, Rached, et al. "Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data." CNS Drugs, vol. 40, no. 3, 2026, p. 359, https://doi.org/10.1007/s40263-025-01256-7.